Navigation Links
Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
Date:5/14/2008

CAMBRIDGE, Mass., May 14 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced that the results from its Phase II coronary revascularization trial have been published in the peer-reviewed EuroIntervention Journal. The paper is entitled "Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization. Rationale, protocol design, and haemodynamic results." The manuscript was authored by principal investigator Patrick W. Serruys, MD, PhD and colleagues of the Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, University Medical Centre Rotterdam, The Netherlands.

"Biopure's COR-0002 study in the EuroIntervention Journal demonstrates the potential use of Hemopure (HBOC-201) in patients with coronary artery disease," said Biopure Chairman and CEO Zafiris G. Zafirelis. "Based on the efficacy and safety of the drug in this trial, we believe that Hemopure could be an oxygen bridge to prevent permanent myocardial damage in patients sustaining a heart attack."

The COR-0002 trial is a single-blind, open-label, single-center, cross- over pilot study where subjects underwent coronary balloon occlusion, with and without oxygenated HBOC-201. The primary objective of the study was to test the hypothesis that intracoronary infusion of HBOC-201 during brief, total coronary artery occlusion would preserve left ventricular function. The primary endpoints in COR-0002 were left ventricular diastolic relaxation indices as assessed by left ventricular pressure-volume loops and ST segment changes as assessed via electrocardiograms.

The study concluded that HBOC-201 was indeed capable of preserving left ventricular function, likely through mainte
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Biopure Reports on Meeting with the FDA
2. Biopure Announces 2007 Third Quarter Financial Results
3. Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
4. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
5. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
6. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
7. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
8. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
9. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
10. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
11. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire/--AccordingtoMillenniumResearch...rketintelligence,thenearly$3billionUSmarketfortrau...henextfiveyearsdespitetherecenteconomicslowdown.MR...tthismarketwillremainhighlydynamicoverthenextfivey...npreviouslyunderservedsegmentsofthetraumafixationm...
(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... IntranasalDrugDelivery-USMarketTrends&Analys...l-Drug-Delivery---US-Market-Trends--Analysis.html ...nganexpansionoftherapeuticapplicationsfromthedeliv...yofsystemictherapeuticdrugs.Thefutureofthetechnolo...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ChindexInternational,Inc....ricanproviderofWestern,healthcareproductsandservic...theCompanywillattendthe21stAnnualPiperJaffray,"Unp...09,atthe,NewYorkPalaceHotel. , Managementiscu...ember1,2009,andholdone-on-onemeetingsthroughoutthe...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2FDA Activates VPCI Electronic Registration Account 57462 1FDA Activates VPCI Electronic Registration Account 57462 2Max Muscle Franchising Is Fueled By The Passion Behind The Brand 57460 1Max Muscle Franchising Is Fueled By The Passion Behind The Brand 57460 2Max Muscle Franchising Is Fueled By The Passion Behind The Brand 57460 3Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 1Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 2Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 3
...ega-dose Resveratrol, Sirtuin1 gene Target Discred...(Longevinex(R)) Exert Greater Effect, SAN DIMAS, ...eratrol (rez-vair-ah-trawl) has recently attracted...lecule that allegedly mimics the effects,of a calo...molecule has,taken a dramatic turn in recent month...
...eceipt of CE Mark Clears the Way for Commercializa... Union, MENLO PARK, Calif., Sept. 10 StemCor S...systems for Enabling Regenerative,Medicine(TM), an...,(Conformite European) Mark for its MarrowMiner Sy...ve device used to harvest adult stem cells from,th...
Other Medicine Technology:Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 2Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 3Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged 4StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection 2
(Date:11/27/2009)... Three new interactive anatomy education...Wilkins expand health sciences learning opportunit... Durham, NC (Vocus) November 27, 2009 -- Mo...s (LWW), a division of Wolters Kluwer Health, toda...education apps on the App Store. Clemente’s ...
(Date:11/26/2009)...too big or too heavy can lead to strains or worse ...- There may be nothing wrong with stuffing your tu...o the same thing with your suitcase as you pack fo... treated in 2008 in U.S. hospital emergency rooms,...ities for luggage-related injuries, such as muscle...
(Date:11/26/2009)... Benton Communications announces a highl...tem for retailers struggling to make an economic r...er 26, 2009 -- Flu fears is the type of challenge ...ncy room, according to Dr. David Benton, business ...iness growth system – The Rfactor Intensive...
(Date:11/25/2009)...andCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc...RI)coilsandsoftwareandCalgaryScientificInc.,aleadi...ducedawebversionofAegis(TM)Breast4DAdvancedVisuali...firsttrulyzero-footprintWebclientbasedmedicalimagi...M)platformallowsforzero-footprintaccess-requiringn...
(Date:11/25/2009)...CISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMana...Spare the Air Alert forThursday,Novembe...ranyothersolidfuel,bothindoorsandoutdoors. ,, "...tytomorrow,"saidJackBroadbent,executiveofficerofth...thehealthoftheirneighborsandfellowcommunitymembers...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...icant complications in ovarian cancer. A gene impl...cant in the disease than previously realised. Up t...m a mutation in a gene called BRCA1.// In these ca... detail how it works. Now doctors at the Unive...
... in the Community Health, coffee may protect again...n smokers..Researchers analysed data from all new ... a 1 year period from 10 general hospitals.// All ...cluding coffee consumption. Smoking is the mai...
...en developed by a research team from Southampton U...mune system to fight lymphoma,a cancer of the immu... usually identified by the body's immune system, a...late the genetic material which identifies the cel...
...hers at Hopkins University, they have found a way ... the immune system, surpassing an obstacle to cer...ogist Lingho Chengh range from improving the body'...ystem.// They can give rise to any of the various ...
...habit of talking over the telephone with the rece...d be put into problems like that of a temporary st...n France spent an hour on the telephone talking to...blindness in his left eye, together with a ringing...
...erica has developed a micro capsule coated with si...al insulin injection.This microchip works by absor... insulin- producing cells.Some diabetics have to i...ois at Chicago Ms Desai, who presented her finding...
Other Medicine News:Health News:A new study surpasses Gene Therapy Hurdle 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: